GAGatha Adhikari

Gatha Adhikari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gatha Adhikari has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Ethyl Cellulose–Ethanol Ablation in a Human‐Sized 3D Construct of High‐Grade Cervical Dysplasia

    by Gatha Adhikari, Alina Sharma, Kaitlin C. Fogg, Jenna L. Mueller

    Current preclinical models for cervical dysplasia rely on animal systems that poorly mimic human anatomy. To address this and align with emerging initiatives to reduce animal experimentation, we developed a human‐sized, 3D in vitro model of high‐grade cervical dysplasia. The construct integrates normal human fibroblasts, keratinocytes, and SiHa cancer cells within a gelatin methacrylate (GelMA) hydrogel, engineered with a cervical “os” and asymmetric lesion to replicate native human cervical architecture. We utilized this platform to evaluate the efficacy and safety of ethyl cellulose–ethanol (EC–ethanol), a novel ablation therapy designed to mitigate the off‐target leakage associated with traditional ethanol injections. While control injections of pure ethanol resulted in widespread, non‐specific necrosis (approximately 99% cell death), EC–ethanol successfully formed a localized gel depot. High‐resolution mapping of the ablation zone demonstrated that EC–ethanol significantly concentrated cytotoxicity within the dysplastic lesion while preserving surrounding healthy tissue. Margin analysis revealed a sharp therapeutic gradient, with cell death normalizing to background levels within approximately 2 mm of the injection site. These findings validate the translational potential of EC–ethanol as a spatially precise intervention and demonstrate the utility of macro‐scale 3D models as powerful, ethical alternatives to animal testing for optimizing local drug delivery.

  • Open Access

    Development of a novel methyl cellulose hydrogel with physiologically relevant controlled ethanol release for cervical dysplasia ablation

    by Ashleigh M. Jankowski, Erela Imanoel, Gatha Adhikari, Jenna Mueller, Katharina Maisel

    Cervical cancer is a leading cause of death in women in low‐ and middle‐income countries (LMICs) and disproportionately affects women of minority populations in the United States, primarily due to a lack of infrastructural support for specialized care. A promising treatment that meets accessibility requirements is ethyl cellulose (EC)‐ethanol ablation—inducing necrotic cell death through application of ethanol to kill precancerous cells. While previous work focused on injecting EC‐ethanol to ablate high‐grade dysplasia (which can reach depths up to 5 mm below the tissue surface), low‐grade dysplasia requires a different delivery method as it is much more superficial (reaching depths of only 1–3 mm). Here, we have developed a topical gel for local ethanol ablation of low‐grade dysplasia with minimal damage to healthy cervical tissue. We investigated several gellants, including methyl cellulose (MC), EC, and Pluronic® F‐127, to develop an ethanol gel that meets parameters for low cost and topical ease of use. Formulations with F‐127 did not form gels with ethanol. Formulations with EC and MC were gel‐forming. The MC‐based formulations formed more uniform and stable gels that hold their own weight while still being spreadable at both room and body temperatures, key criteria for local cervical application. The optimal formulation contained 70% ethanol, 20% water, and 10% MC. One gram of this formulation represents approximately 5¢ material cost, and formulated gels were stable for at least 1 week when stored at 4, 22, 30, and 37°C. Additionally, the MC gel achieved localized ablation within 5 min after application to cervical cancer cells in vitro. Taken together, we have developed a low‐cost, efficacious, MC‐based ethanol gel fit for translational testing to treat low‐grade cervical dysplasia. This gel may provide a novel treatment option for women in LMICs, without causing major side effects or loss of healthy cervical tissue.


  • Impact of Injection-Based Delivery Parameters on Local Distribution Volume of Ethyl-Cellulose Ethanol Gel in Tissue and Tissue Mimicking Phantoms

    by Gatha Adhikari, Venkata Polavarapu Sarojasamhita, Vené Richardson-Powell, Asma Farooqui, Maya Budzinski, David T. Garvey, Jeffrey Yang, David Katz, Brian Crouch, Nimmi Ramanujam, et al.

    Objective: Local drug delivery aims to minimize systemic toxicity by preventing off-target effects; however, injection parameters influencing depot formation of injectable gels have yet to be thoroughly studied. We explored the effects of needle characteristics, injection depth, rate, volume, and polymer concentration on gel ethanol distribution in both tissue and phantoms. Methods: The polymer ethyl cellulose (EC) was added to ethanol to form an injectable gel to ablate cervical precancer and cancer. Tissue mimicking phantoms composed of 1% agarose dissolved in deionized water were used to establish overall trends between various injection parameters and the resulting gel distribution. Additional experiments were performed in excised swine cervices with a CT-imageable injectate formulation, which enabled visualization of the distribution without tissue sectioning. Results: Needle type and injection rate had minimal impact on gel distribution, while needle depths ≥13 mm yielded significantly larger distributions. Needle gauge and EC concentration impacted injection pressure with maximum gel distribution achieved when the pressure was 70–250 kPa. Injection volumes ≤3 mL of 6% EC-ethanol minimized fluid leakage away from the injection site. Results guided the development of a speculum-compatible hand-held injector to deliver gel ethanol into the cervix. Conclusion: Needle depth, gauge, and polymer concentration are critical to consider when delivering injectable gels. Significance: This study addressed key questions related to the impact of injection-based parameters on gel distribution at a scale relevant to human applications including: 1) how best to deliver EC-ethanol into the cervix and 2) general insights about injection protocols relevant to the delivery of injectable gels in tissue.